Inspra Helps, Natrecor Useless for Heart Patients
By wchung | 13 Mar, 2026
There’s good news for millions of people with mild or moderate heart failure. Studies show that the Pfizer drug Inspra and an implanted device from Medtronic can boost survival and cut down on trips to the hospital.
However, another drug that has been used for nearly a decade, Johnson & Johnson’s Natrecor (NAY’-treh-kor), did little to help people with severe heart failure in a study aimed at resolving safety concerns. Doctors say the drug seems safe but does not markedly help shortness of breath or save lives.
The studies were presented Sunday at an American Heart Association conference in Chicago.
MARILYNN MARCHIONE, AP Medical Writer CHICAGO
Articles
- ByteDance Got Around Block on Nvidia Blackwell Chips
- Meta Delays Avocado AI Model Debut, May License Gemini in Interim
- US Seeks to Invalidate California Higher Emissions Standards
- Which Chinese EV Giant Has the Brightest Future in the Global Market?
- Rivian Rolls Out $58k R2, Promises Cheaper Variants to Come
- Iran Maintains Normal Oil Tanker Flow Through Strait of Hormuz
- US Anti-Drone Laser System Poses Risk to Airliners Says Democrat Senator
- China Imposes Mandarin First Law Over Ethnic Minorities
- Software CEOs Counter AI Threat with Swift AI Adoption and Data Moat
- China's Teapots Enjoy Profit Surge Until Oil Supplies Run Out